Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions

EMBO Journal

Volumn 15, Issue 10, 1996, Pages 2452-2467

  Pinkas Kramarski, Ronit ^a   Soussan, Lior ^a   Waterman, Hadassa ^a   Levkowitz, Gil ^a   Alroy, Iris ^a   Klapper, Leah ^a   Lavi, Sara ^a   Seger, Rony ^a   Ratzkin, Barry J ^b   Sela, Michael ^a   Yarden, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b AMGEN INC   (United States)

Author keywords

Growth factors; Oncogene; Receptor dimerization; Signal transduction; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 3; NEU DIFFERENTIATION FACTOR;

ARTICLE; ENDOCYTOSIS; HUMAN; HUMAN CELL; MITOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 2142843806     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00603.x     Document Type: Article

References (67)

1. Alimandi,M., Romano,A., Curia,M.C, Muraro,R., Fedi,P., Aaronson, S.A., Di Fiore,P.P. and Kraus,M.H. (1995) Cooperative signaling of ErbB-3 and ErbB-2 in neoplastic transformation and human mammary carcinoma cells. Oncogene, 10, 1813-1821.
2. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol., 15, 5789-5799.
3. Andrew,N.C. and Faller,D.V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19, 2499-2504.
4. Beerli,R.R., Wels,W. and Hynes,N.E. (1994) Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J. Biol. Chem., 269, 23931-23936.
5. Ben-Levy,R., Peles,E., Goldman-Michael,R. and Yarden,Y. (1992) An oncogenic point mutation confers high affinity ligand binding to the neu receptor. J. Biol. Chem., 267, 17304-17313.
6. Ben-Levy,R., Paterson,H.F., Marshall,C.J. and Yarden,Y. (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP-kinase pathway. EMBO J., 13, 3302-3311.
7. Carraway,K.L. and Cantley,L.C. (1994) A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell, 78, 5-8.
8. Carraway,K.L., Sliwkowski,M.X., Akita,R., Platko,J.V., Guy,P.M., Nuijens,A., Diamonti,A.J., Vandlen,R.L., Cantley,L.C. and Cerione,R.A. (1994) The erbB3 gene product is a receptor for heregulin. J. Biol. Chem., 269, 14303-14306.
9. Carraway,K.L., Soltoff,S.P., Diamonti,A.J. and Cantley,L.C. (1995) Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem., 270, 7111-7116.
10. Chen,X., Levkowitz,G., Tzahar,E., Karunagaran,D., Lavi,S., Ben-Baruch,N., Leitner,O., Ratzkin,B.J., Bacus,S.S. and Yarden,Y. (1996) An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem., 271, in press.
11. Connelly,P.A. and Stern,D.F. (1990) The epidermal growth factor receptor and the product of the neu proto-oncogene are members of a receptor tyrosine phosphorylation cascade. Proc. Natl Acad. Sci. USA, 87, 6054-6057.
12. Damell,J.E.J., Kerr,I.M. and Stark,G.R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415-1421.
13. Di Fiore,P.P., Segatto,O., Taylor,W.G., Aaronson,S.A. and Pierce,J.H. (1990) EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science, 248, 79-83.
14. Dougall,W.C., Qian,X., Peterson,N.C. Miller,M.J., Samanta,A. and Greene,M. (1994) The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 9, 2109-2123.
15. Fantl,W.J., Johnson,D.E. and Williams,L.T. (1993) Signalling by receptor tyrosine kinases. Annu. Rev. Biochem., 62, 453-481.
16. Fedi,P, Pierce,J., Di Fiore,P.P. and Kraus,M.H. (1994) Efficient coupling with phosphatidylinosilol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol., 14, 492-500.
17. Goldman,R., Ben-Levy,R., Peies,E. and Yarden,Y. (1990) Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry, 29, 11024-11028.
18. Graus-Porta,D., Beerli,R.R. and Hynes,N.E. (1995) Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol., 15, 1182-1191.
19. Greenberger,J.S., Sakakeeny,M.A., Humphries,R.K., Eaves,C.J. and Eckner,R.J. (1983) Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc. Natl Acad. Sci. USA, 80, 2931-2935.
20. Guy,P.M., Platko,J.V., Cantley,L.C., Cerione,R.A. and Carraway,K.L. (1994) Insect cell-expressed p 180ErbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
21. Hammacher,A., Mellstrom,K., Heldin,C.-H. and Westermark,B. (1989) Isoform-specific induction of actin reorganization by platelet-derived growth factor suggests that the functionally active receptor is a dimer. EMBO J., 8, 2489-2495.
22. Heldin,C.-H. (1995) Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
23. Hibi,M., Lin,A., Smeal,T., Minden,A. and Karin,M. (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7, 2135-2148.
24. Holmes,W.E. et al. (1992) Identification of heregulin, a specific activator of p185erbB2. Science, 256, 1205-1210.
25. Karasuyama,H. and Melchers,F. (1988) Establishment of mouse cell lines that constitutively secrete large quantities of interleukins 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol., 18, 97-104.
26. Karunagaran,D., Tzahar,E., Liu,N., Wen,D. and Yarden,Y. (1995) Neu differentiation factor inhibits EGF binding: a model for trans-regulation within the ErbB family of receptor tyrosine kinases. J. Biol. Chem., 270, 9982-9990.
27. Karunagaran,D., Tzahar,E., Beerli,R.R., Chen,X., Graus-Porta,D., Ratzkin,B., Seger,R., Hynes,N.E. and Yarden,Y. (1996) ErbB-2 is a common signaling subunit of NDF- and EGF-receptors: implications for breast cancer. EMBO J., 15, in press.
28. Kashles,O., Yarden,Y., Ullrich,A. and Schlessinger,J. (1991) A dominant negative mutation suppresses the function of normal EGF-receptor by heterodimerization. Mol. Cell. Biol., 11, 1454-1463.
29. Kelman,Z., Simon-Chazoltes,D., Guenet,J.-L. and Yarden,Y. (1993) The murine vik gene (Chromosome 9) encodes a putative receptor with unique protein kinase motifs. Oncogene, 8, 37-44.
30. Kim,H.-H., Sierke,S.L. and Koland,J.G. (1994) Epidermal growth factor-dependent association of phosphatidylinositol 3′-kinase with the erbB-3 gene product. J. Biol. Chem., 269, 24747-24755.
31. King,C.R., Borrello,I., Bellot,F. Comoglio,P. and Schlessinger,J. (1988) EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SKBR-3. EMBO J., 7, 1647-1651.
32. Kita,Y.A., Braff,J., Luo,Y, Wen,D., Brankow,D., Hu,S., Prigent,S.A., Gullick,W.J. and Nicolson,M. (1994) NDF/heregulin stimulates the phosphorylation of HER3/erbB3. FEBS Lett., 349, 139-143.
33. Kokai,Y., Myers,J.N., Wada,T., Brown,V.I., LeVea,C.M., Davis,J.G., Dobashi,K. and Greene,M.I. (1989) Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292.
34. Langdon,W.Y., Hartley,J.W., Klinken,S.R., Ruscetti,S.K. and Morse,H. (1989) v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl Acad. Sci. USA, 86, 1168-1172.
35. Leevers,S.J. and Marshall,C.J. (1992) Activation of extracellular signal-regulated kinase. ERK2. by p21ras oncoprotein. EMBO J., 11, 569-574.
36. Lonardo,F., Di Marco,E., King,C.R., Pierce,J.H., Segatto,O., Aaronson,S.A. and Di Fiore,P.P. (1990) The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol., 2, 992-1003.
37. Marikovsky,M., Lavi,S., Pinkas-Kramarski,R., Karunagaran,D., Liu,N., Wen,D. and Yarden,Y. (1995) ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene, 10, 1403-1411.
38. Markowitz,D., Goff,S. and Bank,A. (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol., 62, 1120-1124.
39. Marshall,C.J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
40. Miller,A.D. and Rosman,G.J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques, 7, 980-990.
41. Mosman,T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
42. Munson,P.J. and Rodbard,D. (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
43. Nocka,K., Tan,J., Chin,T.Y., Ray,P., Traktman,P. and Besmer,P. (1990) Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J., 9, 1805-1813.
44. Pandiella,A., Beguinot,L., Velu,T.J. and Meldolesi,J. (1988) Transmembrane signalling at epidermal growth factor receptors overexpressed in NIH 3T3 cells. Biochem. J., 254, 223-228.
45. Peles,E. and Yarden,Y. (1993) Neu and its ligands: from an oncogene to neural factors. BioEssays, 15, 815-824.
46. Peles,E., Ben-Levy,R., Tzahar,E., Naili,L, Wen,D. and Yarden,Y. (1993) Cell-type specific interaction of Neu differentiation factor (NDF/ heregulin) with Neu/HER-2. EMBO J., 12, 961-971.
47. Pelicci,G. et al. (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogen signal transduction. Cell, 70, 93-104.
48. Plowman,D.G., Culouscou,J.-M., Withney,G.S., Green,J.M., Carlton, G.W., Foy.L., Neubauer,M.G. and Shoyab,M. (1993a) Ligand-specific activation of HER-4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl Acad. Sci. USA. 90, 1746-1750.
49. Plowman,G.D., Green,J.M., Culouscou,J.-M., Carlton,G.W., Rothwell, V.M. and Sharon,B. (1993b) Heregulin induces tyrosine phosphorylation of HER4/p180erbB-4. Nature, 366, 473-475.
50. Prigent,S.A. and Gullick,W.J. (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J., 13, 2831-2841.
51. Segatto,O., Pelicci,G., Giuli,S., Digiesi,G., Di Fiore,P.P, McGlade,J., Pawson,T. and Pelicci,P.G. (1993) She products are substrates of erbB-2 kinase. Oncogene, 8, 2105-2112.
52. Seger,R. and Krebs,E.G. (1995) The MAP kinase signaling cascade. FASEB J., 9, 726-735.
53. Seidel,H.M., Milocco,H.L., Lamb,P., Darnell,J.E., Stein,R.B. and Rosen,J. (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl Acad. Sci. USA, 92, 3041-3045.
54. Sliwkowski,M.X. et al. (1994) Coexpression of erbB2 and erbB-3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269, 14661-14665.
55. Soltoff,S.P., Carraway,K.L., Prigent,S.A., Gullick,W.G. and Cantley,L.C. (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14, 3550-3558.
56. Soos,M.A., Whittaker,J., Lammers,R., Ullrich,A. and Siddle,K. (1990) Receptors for insulin and insulin-like growth factor I form hybrid dimers. Biochem. J., 270, 383-390.
57. Spivak-Kroizman,T., Rotin,D., Pinchasi,D., Ullrich,A., Schlessinger,J. and Lax,I. (1992) Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses. J. Biol. Chem., 267, 8056-8063.
58. Stancovski,I., Hurwitz,E., Leitner,O., Ullrich,A., Yarden,Y. and Sela,M. (1991) Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB-2 receptor on tumor growth. Proc. Natl Acad. Sci. USA. 88, 8691-8695.
59. neu: a potential model for receptor interactions. EMBO J., 7, 995-1001.
60. Tzahar,E. et al. (1994) ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all NDF/heregulin isoforms. J. Biol. Chem., 269, 25226-25233.
61. Ullrich,A. and Schlessinger,J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell. 61, 203-212.
62. van der Geer,P., Hunter,T. and Lindberg,R.A. (1994) Receptor prolein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol., 10, 251-337.
63. neu protein and EGF receptor modulates EGF receptor function. Cell, 61, 1339-1347.
64. Wallasch,C., Weiss,F.U., Niederfellner,G., Jallal,B., Issing,W. and Ullrich,A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
65. Wen,D. et al. (1992) Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell. 69, 559-572.
66. Yarden,Y., Gabbay,M. and Schlessinger,J. (1981) Primary amines do not prevent the endocytosis of epidermal growth factor into 3T3 fibroblasts. Biochim. Biophys. Acta, 674, 188-203.
67. Yoon,C.H., Lee,J., Jongeward,G.D. and Sternberg,P.W. (1995) Similarity of sli-1, a regulator of vulval development in C. elegans. to the mammalian proto-oncogene c-Cbl. Science, 269, 1102-1105.